MX2015010305A - Vacuna de combinacion para virus sincitial respiratorio e influenza. - Google Patents

Vacuna de combinacion para virus sincitial respiratorio e influenza.

Info

Publication number
MX2015010305A
MX2015010305A MX2015010305A MX2015010305A MX2015010305A MX 2015010305 A MX2015010305 A MX 2015010305A MX 2015010305 A MX2015010305 A MX 2015010305A MX 2015010305 A MX2015010305 A MX 2015010305A MX 2015010305 A MX2015010305 A MX 2015010305A
Authority
MX
Mexico
Prior art keywords
influenza
respiratory syncytial
syncytial virus
combination vaccine
combination
Prior art date
Application number
MX2015010305A
Other languages
English (en)
Inventor
Gale E Smith
Greg Glenn
Lou Fries
James F Young
Original Assignee
Novavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novavax Inc filed Critical Novavax Inc
Publication of MX2015010305A publication Critical patent/MX2015010305A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

La presente descripción se refiere a composiciones y métodos para formular respuestas inmunitarias contra virus de influenza y virus sincitial respiratorio al administrar una combinación inmunogénica de combinación contra ambos virus al mismo tiempo. Las composiciones de combinación contienen un componente de RSV y uno, dos, tres, cuatro, o más componentes de influenza. Las composiciones de combinación proporcionan una mayor respuesta inmunitaria que aquella obtenida al administrar de manera separada los componentes de RSV y de influenza.
MX2015010305A 2013-02-11 2014-02-11 Vacuna de combinacion para virus sincitial respiratorio e influenza. MX2015010305A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361763309P 2013-02-11 2013-02-11
US201361875327P 2013-09-09 2013-09-09
PCT/US2014/015725 WO2014124423A1 (en) 2013-02-11 2014-02-11 Combination vaccine for respiratory syncytial virus and influenza

Publications (1)

Publication Number Publication Date
MX2015010305A true MX2015010305A (es) 2015-11-18

Family

ID=50185053

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015010305A MX2015010305A (es) 2013-02-11 2014-02-11 Vacuna de combinacion para virus sincitial respiratorio e influenza.

Country Status (13)

Country Link
US (1) US20140227309A1 (es)
EP (1) EP2953642A1 (es)
JP (1) JP2016509015A (es)
KR (1) KR20150138184A (es)
CN (1) CN105101992A (es)
AU (1) AU2014214590A1 (es)
BR (1) BR112015019126A2 (es)
CA (1) CA2900489A1 (es)
IL (1) IL240504A0 (es)
MX (1) MX2015010305A (es)
RU (1) RU2015138530A (es)
SG (1) SG11201506197TA (es)
WO (1) WO2014124423A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11446374B2 (en) 2008-12-09 2022-09-20 Novavax, Inc. Modified RSV F proteins and methods of their use
HUE051666T2 (hu) 2008-12-09 2021-03-29 Novavax Inc Módosított RSV F fehérjék és alkalmazásuk módszerei
US9149521B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9504743B2 (en) 2013-09-25 2016-11-29 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9149522B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US20150086592A1 (en) 2013-09-25 2015-03-26 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US10220086B2 (en) 2014-12-19 2019-03-05 Oregon Health & Science University Synergistic co-administration of computationally optimized broadly reactive antigens for H1N1 influenza
CN114699519A (zh) * 2015-09-03 2022-07-05 诺瓦瓦克斯股份有限公司 具有改进的稳定性和免疫原性的疫苗组合物
CN106822887A (zh) * 2017-01-26 2017-06-13 中国科学院微生物研究所 一种流感病毒四价亚单位疫苗及其应用
CN107961371B (zh) * 2017-04-19 2020-08-11 武汉博沃生物科技有限公司 季节流感-rsv联合疫苗及其制备方法和应用
BR112020019108A2 (pt) 2018-03-19 2020-12-29 Novavax, Inc. Vacinas polivalentes de nanopartículas de influenza
CN110559434B (zh) * 2018-06-05 2022-08-19 普莱柯生物工程股份有限公司 一种禽流感病毒样颗粒疫苗、及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169395B1 (en) * 1998-12-17 2007-01-30 Sanofi Pasteur Limited Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation
JP2010522540A (ja) * 2007-03-21 2010-07-08 アイディー バイオメディカル コーポレイション オブ ケベック キメラ抗原
PT2540312E (pt) * 2007-07-19 2015-08-31 Novavax Inc Vlps quiméricas de gripe aviária
HUE051666T2 (hu) * 2008-12-09 2021-03-29 Novavax Inc Módosított RSV F fehérjék és alkalmazásuk módszerei

Also Published As

Publication number Publication date
EP2953642A1 (en) 2015-12-16
CN105101992A (zh) 2015-11-25
US20140227309A1 (en) 2014-08-14
IL240504A0 (en) 2015-09-24
SG11201506197TA (en) 2015-09-29
WO2014124423A1 (en) 2014-08-14
CA2900489A1 (en) 2014-08-14
BR112015019126A2 (pt) 2017-08-22
AU2014214590A1 (en) 2015-08-27
JP2016509015A (ja) 2016-03-24
RU2015138530A (ru) 2017-03-20
KR20150138184A (ko) 2015-12-09

Similar Documents

Publication Publication Date Title
MX2015010305A (es) Vacuna de combinacion para virus sincitial respiratorio e influenza.
WO2017070626A3 (en) Respiratory virus vaccines
EA201800108A1 (ru) Вакцинные композиции для профилактики абровирусных инфекций
HK1214962A1 (zh) 流感病毒免疫原性組合物及其應用
WO2015168379A3 (en) Combination vaccine devices and methods of killing cancer cells
MX2021002168A (es) Compuestos antivirales.
WO2011103453A3 (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease
WO2016019134A8 (en) Flagellin-based agents and uses including effective vaccination
WO2015085318A3 (en) Targeted adaptive vaccines
MX2021001053A (es) Vacunas contra virus de la influenza y sus usos.
EA202090675A3 (ru) Стабилизированные растворимые f-полипептиды rsv до слияния
NZ704584A (en) Liquid stable virus vaccines
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
PH12015502588B1 (en) 4`-fluoro-2`-methyl substituted nucleoside derivatives
NZ630831A (en) Compositions and methods for administration of vaccines against dengue virus
PH12016502002A1 (en) Novel bacteriophage and composition comprising same
PH12015501716B1 (en) Anti-mycoplasma spp. subunit vaccine
MX2020005554A (es) Vacunas y composiciones inmunogenas para zika y metodos para usarlas.
MX2019005102A (es) Poxvirus quimericos sinteticos.
EP3057611A4 (en) Thermostable respiratory synctial virus (rsv) vaccine compositions
BR112018074910A2 (pt) composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito
BR112016019893A2 (pt) composições de glicoproteína sialilada e seus usos
WO2014167582A3 (en) Vaccine composition for prophylaxis in ruminants
MX2014001158A (es) Virus recombinantes de influenza porcina y usos del mismo.
MX2015010763A (es) Proteinas h5 del virus de la gripe h5n1 para uso como un medicamento.